The effect of social determinants on immunization programs

Cremin, Suzanne M; Menton, J.; Canier, Lydie; Horgan, Mary; Fanning, Liam J.

doi:10.4161/hv.20122

Cited by 12 publications

(7 citation statements)

References 95 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The systematic review of the literature in this study allowed the identification of 84 papers in PubMed and our retrieved references of which 12 fulfilled the inclusion criteria including a total of 1,844 individual’s data [Yun and Joblin, 1993; Vandepapeliere et al, 2005; Potocnik et al, 2007; Aubin et al, 2008; Garland et al, 2009; Arima et al, 2010; Anic et al, 2011; Ball et al, 2011; Jaberipour et al, 2011; Cremin et al, 2012; Jamshidi et al, 2012; Komlos et al, 2012] (see Appendix). …”

Section: Discussionmentioning

confidence: 99%

Distribution of genital wart human papillomavirus genotypes in China: A multi-center study

Chang

Shi

et al. 2013

J. Med. Virol.

View full text Add to dashboard Cite

Although it is understood that low-risk human papillomavirus (HPV) genotypes are associated with genital warts, there have been very few published studies reporting the genotype-specific prevalence of HPV among Chinese population. The aim of the study was to assess the prevalence of HPV genotypes in genital warts across China, and thus to evaluate the potential benefit of a quadrivalent HPV vaccine in this population. The tissue samples of a total of 1,005 genital warts cases were collected from seven geographical regions of China. HPV genotypes were analyzed using the general primer PCR and sequence-based typing method. Prevalence differences between sexes, geographical regions and age groups were assessed. The overall prevalence of HPV DNA in genital warts patients was 88.7% (891/1,005). Low-risk genotypes predominated, with a prevalence of 78.1% (785/1,005). The most prevalent genotypes were HPV-6 (41.3%), HPV-11 (37.6%) and HPV-16 (10.4%). Among HPV positive patients, single infections were more frequent (866/891, 97.2%) than co-infections (25/891, 2.8%). Both the overall prevalence of HPV DNA and that of HPV-6/-11/-16 (positive for any of the three types) decreased with age (P-trend = 0.010 and P-trend = 0.025, respectively). The prevalence of HPV-6/-11 (positive for either HPV type) and HPV-16 varied by geographic region (P = 0.003 and P ≤ 0.001, respectively). The prevalence of HPV-16 in female patients between urban and rural areas showed a marginally significant difference (P = 0.05). In sum, the results provide strong evidence that, in China, the most prevalent HPV genotypes in genital warts are HPV-6, HPV-11 and HPV-16. This indicates that a quadrivalent HPV vaccine may decrease the incidence of genital warts in the future.

show abstract

Section: Discussionmentioning

confidence: 99%

Distribution of genital wart human papillomavirus genotypes in China: A multi-center study

Chang

Shi

et al. 2013

J. Med. Virol.

View full text Add to dashboard Cite

show abstract

“…For instance, in the U.S., individuals who reside in certain metropolitan statistical areas (MSA), non-MSA (mostly rural), and without health insurance are disproportionately less likely to be vaccinated ( 21 ). Additionally, parental education; household living conditions and income; healthcare access; philosophical and cultural beliefs; religious affiliations; and urban Vs. rural residence, are some of the SDoH that influence childhood vaccination rates ( 22 ). In recent times, the COVID-19 pandemic has underscored the importance of incorporating SDoH into health systems and health service delivery.…”

Section: Barriers To Childhood/adolescent Vaccination Uptake During Tmentioning

confidence: 99%

“…Following larger multiple studies and a wealth of scientific evidence, this hypothesized link was disproved and the safety of the MMR vaccine reinforced ( 29 , 30 ). Likewise, fears regarding administering multiple vaccines concurrently in a child, unverified sources, and misinformation campaigns from the internet/media have served to dissuade parents from seeking child vaccination services ( 22 ). Nevertheless, evidence-focused literature has debunked numerous myths and misinformation citing that recommended vaccines are too many; contain unfavorable ingredients e.g., mercury, aluminum, DNA fragments; damage immune and neurologic systems; and display life-threatening side-effects, etc.…”

Section: Barriers To Childhood/adolescent Vaccination Uptake During Tmentioning

confidence: 99%

Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic

et al. 2021

View full text Add to dashboard Cite

Routine childhood immunizations are proven to be one of the most effective public health interventions at controlling numerous deadly diseases. Therefore, the CDC recommends routine immunizations for children and adolescent populations against vaccine-preventable diseases e.g., tetanus, pertussis, diphtheria, etc. This current review sought to examine barriers to pediatric vaccine uptake behaviors during the COVID-19 pandemic. We also explored the implications for parental vaccine hesitancy/delay during an ongoing health crisis and proposed recommendations for increasing vaccine confidence and compliance. Our review determined that the receipt for vaccinations steadily improved in the last decade for both the United States and Tennessee. However, this incremental progress has been forestalled by the COVID-19 pandemic and other barriers i.e. parental vaccine hesitancy, social determinants of health (SDoH) inequalities, etc. which further exacerbate vaccination disparities. Moreover, non-compliance to routine vaccinations could cause an outbreak of diseases, thereby, worsening the ongoing health crisis and already strained health care system. Healthcare providers are uniquely positioned to offer effective recommendations with presumptive languaging to increase vaccination rates, as well as, address parental vaccine hesitancy. Best practices that incorporate healthcare providers’ quality improvement coaching, vaccination reminder recall systems, adherence to standardized safety protocols (physical distancing, hand hygiene practices, etc.), as well as, offer telehealth and outdoor/drive-through/curbside vaccination services, etc. are warranted. Additionally, a concerted effort should be made to utilize public health surveillance systems to collect, analyze, and interpret data, thereby, ensuring the dissemination of timely, accurate health information for effective health policy decision-making e.g., vaccine distribution, etc.

show abstract

“…This includes … the capacity of the government to effectively formulate and implement sound policies; and the respect of citizens and the state for the institutions that govern economic and social interactions among them”. The role of governance is shared between government, public administration, and other economic and institutional organizations and plays a basic role for crisis management ( Coccia, 2021b ; Glatman-Freedman and Nichols, 2012 ).…”

Section: Introductionmentioning

confidence: 99%

Preparedness of countries to face COVID-19 pandemic crisis: Strategic positioning and factors supporting effective strategies of prevention of pandemic threats

Coccia

2022

Environmental Research

220

136

View full text Add to dashboard Cite

The Coronavirus Disease 2019 (COVID-19) continues to generate a constant pandemic threat with new mutations of the viral agent that create socioeconomic issues. One of the fundamental problems is the evaluation of the preparedness of countries to cope with COVID-19 pandemic crisis to detect factors associated with the reduction of infectious disease and rollout of vaccinations in society. The study here confronts this problem by developing two basic indexes, which measure the performance to face pandemic threats by countries. In particular, the Index r (as resilience ) detects which countries have had the best performance to reduce the negative impact of mortality related to COVID-19 pandemic and the Index p (as preparedness and prevention ) assesses best-performer countries to support COVID-19 vaccinations to constrain future pandemic threats and support the recovery of socioeconomic systems. Index of resilience is a composite measure based on three indicators, given by average mortality, hospital occupancy and Intensive Care Units occupancy per 100 000 people, producing an overall score; Index of prevention is also a composite measure of two indicators related COVID-19 vaccinations (doses of vaccines administrated and total vaccinates per 100 000 people), producing an overall score. The application of these indexes on a case study of European countries, having a homogenous socioeconomic area, shows strategic positioning of countries to cope with a major pandemic threat. Findings reveal that all countries have some weaknesses and no country has a high preparedness to cope with a major epidemic or pandemic. Moreover, results suggest that best-performer countries to cope with COVID-19 pandemic crisis have a smaller size of population and better public governance, associated with high expenditures in health system. These indexes can help policymakers for designing strategies to improve preparedness to face future pandemic threats.

show abstract

The effect of social determinants on immunization programs

Cited by 12 publications

References 95 publications

Distribution of genital wart human papillomavirus genotypes in China: A multi-center study

Distribution of genital wart human papillomavirus genotypes in China: A multi-center study

Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic

Preparedness of countries to face COVID-19 pandemic crisis: Strategic positioning and factors supporting effective strategies of prevention of pandemic threats

Contact Info

Product

Resources

About